# A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)

> **NCT03363451** · — · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- End Stage Liver Disease
- Infection

## Interventions

- **DRUG:** Antibiotics

## Key facts

- **NCT ID:** NCT03363451
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2018-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363451, "A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03363451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*